Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"PROSPER-FM": Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management

NCT05243511 is registered in ClinicalTrials.gov with Swing Therapeutics, Inc. as lead sponsor.

NCT NCT05243511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05243511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"PROSPER-FM": Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management
Lead sponsor
Swing Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 8, 2022
Completion date
May 15, 2023
Enrollment
275 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia